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ABSTRACT: Congenital heart defects (CHO) comprise the commonest group of malformations 
and ventricular septal defect (VSO) is the most prevalent type of CHO most frequently requiring 
corrective surgery. There has been an increase in the number of Maltese patients operated for this 
condition over 1930-1994 which has now stabilised. Peri-operative mortality has declined, 
paralleled by a significant decline in age at surgery. The birth prevalence of VSD requiring surgery 
is 0.83/1000 live births with a surgical rate of 0.88 operations/lOOO live births including primary 
operations and reoperations. Approximately 122,000 children are born with this condition annually 
world-wide at an estimated potential surgical cost of £2,280,000,000. 
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Introduction 
Congenital heart disease (CHD) is a label for a 
heterogeneous set of lesions which comprise the 
commonest group of congenital malformations, and 
ventricular septal defect (VSD) is the commonest form 
of CHD 1. Malta is an ideal setting for studies dealing 
with historical trends in treatment due to the relatively 
closed and captive nature of the population. 
This paper identifies all Maltese patients diagnosed as 
having haemodynamically significant VSD requiring 
intervention born up to the end of 1994 and analyses 
trends in age at surgery. method of surgical closure. 
operative centre. perioperative mortality. reoperations 
for VSD and overall trends in number of operations for 
VSD. 
Methods 
Definitions 
CHD was defined as a structural abnormality of the 
heart or intrathoracic great vessels that is actually or 
potentially of functional significance'. Cases with 
multiple CHD diagnoses had their lesions classified 
hierarchically. The most haemodynamically important 
lesion was considered the primary diagnosis throughout. 
VSD was defined as a defect in the interventricular 
septum. Patients with a primary diagnosis of VSD were 
graded by severity into two groups. Mild VSDs were 
those which did not require surgical intervention. Severe 
VSDs were those which required intervention and are the 
subject of this study. Perimembranous defects were those 
located in the upper. perimembranous portion of the 
mterventricular septum, related to the tricuspid valve on 
the right side of the heart and to the aortic valve on the 
left side of the heart. Muscular defects were those 
located more inferioriy in t~e interventricular septum. 
bounded entirely by the muscular septum throughout 
their circumference. 
Diagnosis of VSD was only accepted for inclusion into 
this study if made by echocardiography (available in 
Malta since 1988). cardiac catheterisation. surgery or 
post-mortem. Recent studies dealing with the 
epidemiology of CHD have only included patients 
diagnosed as having CHD by one year of age2 This 
condition was not applied due to the historicai nature of 
the study. 
Patients 
The catchment area for this study was the Maltese 
archipelago. St. Luke's Hospital is the only regional 
hospital in Malta. It caters for the investigation of all 
patients suspected as having CHD. and their follow-up. 
Termination of pregnancy is illegal. hence, there is no 
organised antenatal screening programme for CHD. 
Data sources 
Patients with severe VSD were identified from copies 
of all paediatric echocardiogram reports, registers of 
patients referred. for investigation or treatment abroad, 
local elective catheter lists. visiting consultant 
cardiologist clinic lists. visiting consultant cardiac 
surgical lists and post-mortem reports. Newly diagnosed 
cases of severe VSD born between October and 
December 1994 were entered prospectively. 
Statistics 
Official Maltese publications were used to obtain total 
monthly livebirths from 1990 to 1994}. 
Pearson correlation was used to analyse correlation of 
events with time. 
A p value of 0.05 was taken to represent statistical 
significance. 
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Softwarc 
Patients with CHD were entered onto a dedicated 
dBASE database (MAPCAD: Maltese Paediatric 
Cardiology Database). Diagnoses and interventions were 
coded with a Version 2 Read Codes Browser". A se ries 
of dBASE procedures were used to ex tract data from 
MAPCAD. The data was analysed with Excel 5.0 and 
SPSS. 
Results 
1930-1994 
There were 85 cases of se vere VSD in this period. 
SCI'erc VSD-ul1opcratcd 
10 patients were not operated. The reasons for non­
operation were late diagnosis with irreversible 
pulmonary hypertension (n=5, year of birth: 1930-1986) , 
Down's syndrome (n=3, year of birth: 1967-1973) and 
multiple malformations (n=2. year of birth: 1979-1991). 
Rcopermiol1for VSD 
Ten of the 75 operated VSDs were reoperated (13% ). 
Reasons for reoperation were redo operations (n=4, year 
of 1st operation: 1976-1993), debanding of previous 
pulmonary artery band with closure of multiple VSDs 
(n=3 , year of I st operation: 1966-1993), re-exploration 
in the early postoperative period for tamponade (n= I, 
year of operatIOn: 1987). pacemaker insertion for 
iatrogenic heart block (n= I, year of operation: 1968), 
and aortic valve replacement for associated progressive 
aortic valvar stenosis (n= I). 
5 ycarlv operation to{(jls and p eri-operatil'e mortality 
The 5 yearly total number of operated VSDs has 
progressively increased from I case in 1955-1959 to 28 
cases in 1990-1994 (Figure 1). The yearly mean number 
of operations for VSD has levelled out at 5.6 cases per 
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operative mortality decreased steadily from 25'10 in 
1975-1979 to OC':!o in 1990-1994. Further analysis of data 
showed a progressive decline in mean age at surgery \T1 
the eras 1965-69. 1970-74, 1975-89 and 1990-94. 
Age (.11 surgery 
There was a significant trend towards earlier age at 
surgery over the period under study (p<O.OOO I) (Figure 
2). This trend was also present but not statistically 
significant slIlce introduction of echocardiography 
(1988-1994 , n=25, r=-0.36, p=0.(7) . 
Melhod of surgery (.Ind cemre 
The method of VSD closure has changed from 
predominantly direct suture up to the late 1970s to 
closure almost exc lusi ve ly by synth etic patch thereafte r. 
Maltese patients were operated mainl y at St. Mary's 
Hospital (Paddington, London) up to the early-I9S0s. 
when the most commonly utili sed centre became the 
Hospital for Sick Children (Great Ormond Street). 
London. 
1990-1994 
The annual VSD figures showed progressi vely fewer 
VSDs prior to 1990, whi le the numbers of defec t~ 
stabilised over 1990-1994. Thi~ period was therefore 
chosen for epidemiological calculations as ascertainment 
s ince 1990 appeared to be complete. All severe defects 
were diagnosed before one year of age allowing standard 
calculations to be made regarding epidemiological 
aspects of VSD. 
The population of Malta is approximately 360,000 and 
there were 26.117 li vebirths in 1990-1994. 
This study showed 22 live births with severe VSD in 
the same period with a birth prevalence of 0.83/IO()() live 
births. Twelve were peri-membranous defects, seven 
were muscular defects and three had mixed defects. 
Three had multiple VSDs (0.11/1000 live-births). Only 
one of these required 2-stage repair with pulmonary 
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Figure 1: 5 year percentage peri-operative mortality for patients operated for VSD. 
(4 operations performed in 1995 not shown) . 
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artery banding prior to total definitive repair. The overall 
operation Irate was 0.88 operations/IOOO live-births 
(including one patient operated twice). 
Down's syndrome accounted for 32% of severe VSD 
(n=7) and one other patient had Holt-Oram syndrome. 
The latter had multiple VSDs. 
Discussion 
Without intervention, 90-95% of patients with CHD 
will die before adolescence5.6 . 
VSD is the commonest form of CHD requiring 
surgical intervention and can therefore be used as an 
indicator of surgical paediatric cardiology services. 
The developments in local paediatric cardiology 
services have run in parallel with services in other 
countries. Since diagnostic and interventional decisions 
were undertaken by visiting consultant cardiologists and 
cardiac surgeons , trends found locally can be 
extrapolated to larger countries with similar paediatric 
cardiology services. 
1930-1994 
There has been a progressive increase in the number of 
operated cases of VSD in the period reviewed which has 
only levelled off since 1990. A striking decline in peri­
operative mortality for VSD was paralleled by a trend 
towards earlier age at surgery. Factors contributing to 
this include improved surgical expertise, experience and 
equipment, and increased local medical awareness of 
CHD and the possibility of successful treatment7.8. 
The decrease in operations after 1975 with subsequent 
pick-up of number of operations was initially thought to 
be due to the reorganisation of the Maltese medical 
services in the decade following 1977. However, further 
analysis of data showed a progressive decline in mean 
age at surgery in the eras 1965-69, 1970-74, 1975-89 and 
1990-94. Although diagnosis may have been delayed in 
the period 1975-89 with subsequent late pick-up in 1990­
94, this would tend to be obscured by a trend towards 
earlier age at diagnosis (and hence surgery) due to 
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improvement in medical and technological trends in the 
last period. 
Other trends in surgical management of VSD include a 
move towards synthetic patch closure of defects rather 
than direct suture since the late 1970s to avoid hean 
block. The only case of surgically induced heart block in 
this series occurred in 1968. 
The operative centre was predominantly St. Mary's 
Hospital (London) up to the early-1980s . This reflects 
the change in visiting cardiologists performing paediatric 
clinics in Malta. Prior to 1985, children were seen by Dr. 
Besterman, an adult cardiologist based at Sl. Mary 's 
Hospital. Children who required cardiac surgery were 
therefore transferred to that centre. In 1985, Dr. Hallidie­
Smith, a paediatric cardiologist, began to see all children 
with CHD. This consultant was initially based at the 
Hammersmith Hospital (London), and later moved to 
Great Ormond Street. Naturally children were operated 
in these centres. Few children have been operated in 
Malta as the natural history of these lesions is that of 
heart failure in infancy, hence surgery is not elective. For 
this reason, cardiac surgery for VSD in infants has only 
been carried out in UK tertiary centres as a semi-urgent 
procedure. 
1990-1994 
Global cost 
The current, open market cost for cardiopulmonary 
bypass surgery in the UK (GOSH and Harley Street 
Clinic, London) is £15,000 for procedures where 
admission to intensive care does not exceed 7 days and 
hospital stay overall does not exceed 14 days (currency 
in sterling), and VSD falls within this category. 
The birth prevalence of severe VSD was 0.83/1000 
live-births with an operation rate of 0.88 operations/IOOO 
live-births. 
The birth prevalence of VSD is the same in differe,nt 
parts of the world 1.6. The current annual live births 
world-wide total around 144,000,0009. This works out to 
an annual number of live births with VSD of around 
119,000 and an annual number of operations of 127,000 
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Figure 2: Age in months at first operation for VSD. 
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world-wide. 
Given the above data, the potential world cost of 
treating this condition in tenns of surgery alone is 
£ I ,900,800,000. This does not include the cost of 
preoperative medical follow-up including investigation 
and possible treatment of heart failure, parental loss of 
work to attend hospital visits and antibiotic prophylaxis. 
However, in many countries, paediatric cardiology 
facilities are unavailable or incomplete. This results in a 
large number of these children dying of heart failure in 
infancy, or from irreversible pulmonary hypertension 
(Eisenmenger syndrome) in their second to third decade 
of life, or from bacterial endocarditis. 
Local cost 
The national budget recurrent expenditure for 1997 is 
estimated at LM493,000,000. The capital and recurrent 
expenditure for the Health budget for 1997 (including 
recurrent expenditure for the care of the elderly) is 
estimated at LM57,000,000. Surgical treatment for VSD 
would account for 0.02% of the total budget and 0.2% of 
the Health budget. In real tenns, surgery for VSD costs 
Malta far less due to the reciprocal Health agreement 
between Malta and the UK which allows 180 new 
Maltese patients per annum to be treated in the UK as 
NHS patients at no extra cost to Malta. Since surgery for 
CHD is one of the most expensive interventions 
undertaken on patients referred for treatment abroad, 
CHD patients are invariably included in this category. 
Conclusion 
VSD which requires surgery is diagnosed early on in 
life by non-invasive echocardiography and carries a very 
low perioperative mortality. Malfonnation statistics from 
small countries with high ascertainment of lesions can 
give insights in past trends of intervention world-wide 
and can estimate costs of treatment on a national or 
global basis. 
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